Mitochondrial GSNOR Alleviates Cardiac Dysfunction via ANT1 Denitrosylation
Xin Tang,Shuang Zhao,Jieqiong Liu,Xiameng Liu,Xinqi Sha,Changgao Huang,Lulu Hu,Shixiu Sun,Yuanqing Gao,Hongshan Chen,Zhiren Zhang,Dongjin Wang,Yuexi Gu,Shaoliang Chen,Liansheng Wang,Aihua Gu,Feng Chen,Jun Pu,Xin Chen,Bo Yu,Liping Xie,Zhengrong Huang,Yi Han,Yong Ji
DOI: https://doi.org/10.1161/circresaha.123.322654
IF: 23.213
2023-06-29
Circulation Research
Abstract:Circulation Research, Ahead of Print. Background:The cardiac-protective role of GSNOR (S-nitrosoglutathione reductase) in the cytoplasm, as a denitrosylase enzyme of S-nitrosylation, has been reported in cardiac remodeling, but whether GSNOR is localized in other organelles and exerts novel effects remains unknown. We aimed to elucidate the effects of mitochondrial GSNOR, a novel subcellular localization of GSNOR, on cardiac remodeling and heart failure (HF).Methods:GSNOR subcellular localization was observed by cellular fractionation assay, immunofluorescent staining, and colloidal gold particle staining. Overexpression of GSNOR in mitochondria was achieved by mitochondria-targeting sequence-directed adeno-associated virus 9. Cardiac-specific knockout of GSNOR mice was used to examine the role of GSNOR in HF. S-nitrosylation sites of ANT1 (adenine nucleotide translocase 1) were identified using biotin-switch and liquid chromatography-tandem mass spectrometry.Results:GSNOR expression was suppressed in cardiac tissues of patients with HF. Consistently, cardiac-specific knockout mice showed aggravated pathological remodeling induced by transverse aortic constriction. We found that GSNOR is also localized in mitochondria. In the angiotensin II–induced hypertrophic cardiomyocytes, mitochondrial GSNOR levels significantly decreased along with mitochondrial functional impairment. Restoration of mitochondrial GSNOR levels in cardiac-specific knockout mice significantly improved mitochondrial function and cardiac performance in transverse aortic constriction–induced HF mice. Mechanistically, we identified ANT1 as a direct target of GSNOR. A decrease in mitochondrial GSNOR under HF leads to an elevation of S-nitrosylation–ANT1 at cysteine 160 (C160). In accordance with these findings, overexpression of either mitochondrial GSNOR or ANT1 C160A, non-nitrosylated mutant, significantly improved mitochondrial function, maintained the mitochondrial membrane potential, and upregulated mitophagy.Conclusions:We identified a novel species of GSNOR localized in mitochondria and found mitochondrial GSNOR plays an essential role in maintaining mitochondrial homeostasis through ANT1 denitrosylation, which provides a potential novel therapeutic target for HF.
cardiac & cardiovascular systems,peripheral vascular disease,hematology